Functionalized peptides as antiviral agents
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof:which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable slat thereof, an...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
14.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof:which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable slat thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof. |
---|---|
Bibliography: | Application Number: US202117522176 |